questionText: To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence's recommendation of relugolix-estradiol-norethisterone for routine NHS use to treat endometriosis will extend to Northern Ireland.
answerText: The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new medicines should be routinely funded by the National Health Service in England. NICE published final draft guidance on 13 March 2025 that recommends relugoli...
heading: Relugolix/estradiol/norethisterone: Northern Ireland